Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-02-11

Clinical Trial Update: Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection [NA]

View source ↗

Summary

A clinical trial evaluating perioperative blood pressure control with clevidipine (Cleviprex) for patients with aortic aneurysm or aortic dissection has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLEVIPREX (clevidipine)

Snippet

Sponsor: Duke University | Conditions: Aorta Aneurysm, Dissection of Aorta | NA | Status: WITHDRAWN